MYGN FY 2012 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$454M

FY 2012 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$613M+23.6% YoY

Gross Profit

$534M87.0% margin

Operating Income

$228M37.2% margin

Net Income

$147M24.0% margin

EPS (Diluted)

$1.77

Cash Flow

Operating Cash Flow

$174M

Free Cash Flow

$163M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$804M

Total Liabilities

$75M

Stockholders' Equity

$729M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$613M	$496M	+23.6%
Gross Profit	$534M	$431M	+23.7%
Operating Income	$228M	$180M	+26.4%
Net Income	$147M	$112M	+31.2%